COMPASS Pathways Archives

Psychedelics News

COMPASS Pathways

Finance

8 May 2023

Which Psychedelic Medicine Companies Have the Best Financials?

As I have written many times before, the success or failure of a psychedelic medicine company depends heavily on its financial position....

By James Hallifax

Industry

2 May 2023

American Medical Association to Issue First Code for Psychedelic Therapies to COMPASS and MAPS

COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, and MAPS Public Benefit Corporation (MAPS PBC), a...

By Microdose NewsDesk

Industry

23 Feb 2023

Compass Pathways’ New Psilocybin For Depression Trial, Explained

On February 17th, psychedelic medicine company Compass Pathways (Nasdaq: CMPS) registered a new Phase 2 clinical trial attempting to treat Major Depressive Disorder using psilocybin-assisted therapy....

By James Hallifax

Industry

4 Jan 2023

Top 3 Psychedelic Storylines to Watch in 2023

2022 was a milestone year for the psychedelic industry, and 2023 is shaping up to be an even more paradigm-shifting....

By James Hallifax

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

9 Aug 2022

Breaking News: Terran Biosciences Sues Compass Pathways for Stealing Trade Secrets

According to the court filings, Compass allegedly entered into negations and signed an NDA with a researcher regarding psilocybin development, before ending the talks and "milking" him for this confidential...

By Microdose NewsDesk

Finance

4 Aug 2022

COMPASS Pathways Announces Q2 Results and Highlights

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights...

By Microdose NewsDesk

Breaking News, Industry

28 Jul 2022

Compass Pathways Launches New Phase 2 Trial for Anorexia

Today we have more positive news, with the firm announcing a new Phase 2 trial using its COMP360 psilocybin for anorexia, taking place at prestigious sites like King's College London...

By Microdose NewsDesk

Don’t Miss

25 Jul 2022

News You Might Have Missed: July 25th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

19 Jul 2022

COMPASS Pathways Appoints Big Pharma CEO

Compass Pathways' George Goldsmith is replaced by Kabir Nath, former Senior Director at pharma giant Otsuka Pharmaceuticals....

By Jason Najum

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result